We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+472.96%
AUM
$475B
AUM Growth
+$21.4B
Cap. Flow
-$8.62B
Cap. Flow %
-1.82%
Top 10 Hldgs %
17.9%
Holding
5,783
New
811
Increased
2,514
Reduced
1,655
Closed
342

Sector Composition

Rank Sector Weight
1 Financials 14.59%
2 Technology 12.2%
3 Healthcare 9.44%
4 Consumer Discretionary 8.6%
5 Industrials 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRPT icon
5376
PUT
Sarepta Therapeutics
SRPT
$1.77B
-101,000
Closed -$4.76M
STIP icon
5377
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
-179
Closed -$18K
TGT icon
5378
PUT
Target
TGT
$68B
-25,000
Closed -$1.47M
THM
5379
International Tower Hill Mines
THM
$604M
$0 ﹤0.01%
500
TJX icon
5380
CALL
TJX Companies
TJX
$178B
-51,000
Closed -$1.89M
TJX icon
5381
PUT
TJX Companies
TJX
$178B
-74,000
Closed -$2.74M
TMO icon
5382
CALL
Thermo Fisher Scientific
TMO
$220B
-50,000
Closed -$9.32M
TNXP icon
5383
Tonix Pharmaceuticals
TNXP
$192M
0
TRIB
5384
Trinity Biotech
TRIB
$8.39M
-482
Closed -$405K
TRVG
5385
trivago
TRVG
$397M
-24,596
Closed -$1.34M
TTD icon
5386
CALL
Trade Desk
TTD
$6.49B
-1,050,000
Closed -$6.12M
TTNP
5387
DELISTED
Titan Pharmaceuticals
TTNP
0
TYG
5388
Tortoise Energy Infrastructure Corp
TYG
$1.08B
-5,373
Closed -$624K
ULBI icon
5389
Ultralife
ULBI
$106M
-428
Closed -$3K
UNH icon
5390
CALL
UnitedHealth
UNH
$370B
-225,400
Closed -$44.2M
URBN icon
5391
PUT
Urban Outfitters
URBN
$6.59B
-9,400
Closed -$225K
URI icon
5392
CALL
United Rentals
URI
$72.4B
-27,000
Closed -$3.73M
URI icon
5393
PUT
United Rentals
URI
$72.4B
-27,000
Closed -$3.73M
VBF icon
5394
Invesco Bond Fund
VBF
$169M
-42
Closed -$1K
VCEL icon
5395
Vericel Corp
VCEL
$2.31B
-58,649
Closed -$328K
VCR icon
5396
PUT
Vanguard Consumer Discretionary ETF
VCR
$6.18B
-800
Closed -$75K
VIAV icon
5397
CALL
Viavi Solutions
VIAV
$9.66B
-166,800
Closed -$1.58M
VIPS icon
5398
PUT
Vipshop
VIPS
$7.53B
-179,600
Closed -$1.65M
VMC icon
5399
PUT
Vulcan Materials
VMC
$36.9B
-10,000
Closed -$1.19M
VNQI icon
5400
Vanguard Global ex-US Real Estate ETF
VNQI
$3.57B
-165
Closed -$9.91K

Similar funds

JP Morgan Chase's Q4 2017 Portfolio in Review

As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
  • JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
  • JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
  • JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
  • JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
  • JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.

Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.